Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v2-FR
Language French French
Date Updated 2020-01-16 2017-06-15
Drug Identification Number 02452162 02452162
Brand name CEFAZOLIN FOR INJECTION CEFAZOLIN FOR INJECTION
Common or Proper name Cefazolin for Injection Cefazolin for Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients CEFAZOLIN CEFAZOLIN
Strength(s) 10G 10G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10g Vial 10g Vial
ATC code J01DB J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-07-03 2017-07-03
Actual start date
Estimated end date 2017-04-13 Unknown
Actual end date 2017-06-07
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments Stockout start date may vary by region; please check your local distribution centre for stock availability. Customers will be allocated 100% of their historical average monthly volumes, effective June 14, 2017.
Health Canada comments